X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2743) 2743
Book Review (387) 387
Publication (246) 246
Book / eBook (14) 14
Book Chapter (11) 11
Newsletter (9) 9
Conference Proceeding (2) 2
Reference (2) 2
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2543) 2543
humans (1537) 1537
male (1384) 1384
fatty acids, nonesterified - blood (1301) 1301
animals (1293) 1293
female (1073) 1073
fatty acids (673) 673
adult (634) 634
endocrinology & metabolism (612) 612
insulin - blood (527) 527
insulin resistance (496) 496
metabolism (485) 485
middle aged (484) 484
blood glucose - metabolism (469) 469
obesity (465) 465
rats (456) 456
triglycerides - blood (456) 456
fatty acids, nonesterified - metabolism (433) 433
glucose (420) 420
abridged index medicus (401) 401
insulin (393) 393
physiological aspects (375) 375
nutrition & dietetics (374) 374
mice (357) 357
insulin-resistance (342) 342
liver - metabolism (323) 323
lipids (314) 314
diet (309) 309
research (261) 261
diabetes (255) 255
physiology (249) 249
lipid metabolism (239) 239
cholesterol - blood (229) 229
liver (229) 229
pregnancy (227) 227
risk factors (224) 224
aged (219) 219
blood glucose - analysis (219) 219
time factors (214) 214
biochemistry & molecular biology (212) 212
rodents (208) 208
triglycerides (202) 202
analysis (201) 201
health aspects (201) 201
adipose-tissue (195) 195
obesity - metabolism (190) 190
lipids - blood (189) 189
glucose - metabolism (188) 188
mice, inbred c57bl (186) 186
oxidative stress (183) 183
metabolic syndrome (182) 182
dextrose (176) 176
diet, high-fat - adverse effects (174) 174
insulin - metabolism (167) 167
triglycerides - metabolism (166) 166
type 2 diabetes (166) 166
glucose tolerance test (165) 165
body weight (163) 163
inflammation (162) 162
liver - drug effects (161) 161
cholesterol (160) 160
food science & technology (157) 157
agriculture, dairy & animal science (154) 154
nutrition (153) 153
adipose tissue - metabolism (146) 146
rats, wistar (142) 142
pharmacology & pharmacy (141) 141
fatty-acids (139) 139
gene expression (138) 138
plasma (137) 137
skeletal-muscle (135) 135
gene-expression (134) 134
glucose metabolism (133) 133
expression (128) 128
rats, sprague-dawley (126) 126
double-blind method (125) 125
insulin resistance - physiology (124) 124
proteins (122) 122
article (120) 120
oxidation (120) 120
dietary fats - adverse effects (118) 118
dietary supplements (117) 117
lipolysis (117) 117
cardiac & cardiovascular systems (114) 114
cattle (113) 113
muscle, skeletal - metabolism (112) 112
disease models, animal (110) 110
adolescent (108) 108
dietary fats - administration & dosage (107) 107
myocardium - metabolism (107) 107
fatty acids - metabolism (106) 106
care and treatment (105) 105
free fatty acids (105) 105
medicine (105) 105
lipid-metabolism (104) 104
dose-response relationship, drug (103) 103
energy metabolism (102) 102
research article (102) 102
body mass index (101) 101
cell biology (101) 101
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2650) 2650
German (56) 56
Italian (15) 15
Japanese (13) 13
Russian (13) 13
French (9) 9
Czech (3) 3
Spanish (3) 3
Chinese (2) 2
Polish (2) 2
Swedish (2) 2
Bulgarian (1) 1
Hungarian (1) 1
Norwegian (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 02/2012, Volume 302, Issue 3, pp. 374 - 386
Laugerette F, Furet J, Debard C, Daira P, Loizon E, Geloen A, Soulage CO, Simonet C, Lefils-Lacourtablaise J, BernoudHubac N, Bodennec J, Peretti N, Vidal H,... 
Lipopolysaccharide-binding protein | sCD14 | Nutrition | Fatty acid | PHYSIOLOGY | (LPS)-BINDING PROTEIN | HUMAN GUT MICROBIOTA | fatty acid | nutrition | ACID-COMPOSITION | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | lipopolysaccharide-binding protein | CARDIOVASCULAR MORTALITY | LOW-GRADE INFLAMMATION | TNF-ALPHA | SATURATED FAT | INDUCED OBESITY | Adipose Tissue, White - immunology | Adipose Tissue, White - metabolism | Diet, High-Fat - adverse effects | Metabolic Diseases - immunology | Male | Fatty Acids, Monounsaturated | Gram-Negative Bacteria - immunology | Gram-Negative Bacteria - isolation & purification | Intestines - immunology | Lipopolysaccharide Receptors - metabolism | Palm Oil | Fatty Acids, Nonesterified - blood | Gram-Positive Bacteria - immunology | Cytokines - blood | Fatty Acids, Nonesterified - adverse effects | Biomarkers - metabolism | Carrier Proteins - blood | Intestines - pathology | Cytokines - metabolism | Acute-Phase Proteins | Mice, Inbred C57BL | Membrane Glycoproteins - blood | Biomarkers - blood | Canola Oil | Random Allocation | 3T3-L1 Cells | Toll-Like Receptor 4 - metabolism | Plant Oils - adverse effects | Lipopolysaccharide Receptors - blood | Animals | Intestines - microbiology | Sunflower Oil | Metabolic Diseases - metabolism | Metabolic Diseases - etiology | Gram-Positive Bacteria - isolation & purification | Mice | Metabolic Diseases - microbiology | Receptors, Immunologic - metabolism | Endotoxins | Physiological aspects | Inflammation | Research | Properties | Cardiovascular diseases | Fatty acids | Health aspects | Ketogenic diet | Risk factors | Obesity | Diet | Metabolism | Rodents | Index Medicus | Intestines | Toll-Like Receptor 4 | Cytokines | Gram-Negative Bacteria | Biological Markers | Antigens, CD14 | Metabolic Diseases | Gram-Positive Bacteria | Life Sciences | Adipose Tissue, White | Diet, High-Fat | Fatty Acids, Nonesterified | Receptors, Immunologic | Food and Nutrition | Plant Oils | Membrane Glycoproteins | Carrier Proteins
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2013, Volume 35, Issue 9, pp. 1400 - 1411.e3
Abstract Background A novel omega-3 formulation in free fatty acid form (OM3-FFA) has as much as 4-fold greater bioavailability than ethyl ester forms and... 
Internal Medicine | Medical Education | hypertriglyceridemia | omega-3 fatty acids | triglycerides | LDL-C | statins | Triglycerides | Hypertriglyceridemia | Omega-3 fatty acids | Statins | EFFICACY | APOLIPOPROTEIN B-100 | ETHYL-ESTERS | RANDOMIZED CONTROLLED-TRIAL | DENSITY-LIPOPROTEIN CHOLESTEROL | DOCOSAHEXAENOIC ACID | DISEASE | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | FISH-OIL | EICOSAPENTAENOIC ACID | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hypertriglyceridemia - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Biological Availability | Fatty Acids, Nonesterified - administration & dosage | Olive Oil | Cardiovascular Diseases - blood | Plant Oils - administration & dosage | Drug Therapy, Combination | Fatty Acids, Nonesterified - adverse effects | Fatty Acids, Omega-3 - administration & dosage | Fatty Acids, Nonesterified - therapeutic use | Double-Blind Method | Drug Administration Schedule | Risk Factors | Combined Modality Therapy | Plant Oils - therapeutic use | Plant Oils - adverse effects | Hypertriglyceridemia - blood | Medication Adherence | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hypertriglyceridemia - complications | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cholesterol, HDL - blood | Fatty Acids, Omega-3 - therapeutic use | Fatty Acids, Omega-3 - blood | Aged | Dietary Supplements | Fatty Acids, Omega-3 - adverse effects | Medical colleges | Hyperlipidemia | Clinical trials | Cardiovascular diseases | Fatty acids | Risk factors | Cardiovascular disease | Diet | Drug therapy | Cholesterol | Index Medicus
Journal Article
Molecular Nutrition & Food Research, ISSN 1613-4125, 08/2015, Volume 59, Issue 8, pp. 1443 - 1457
ScopeResveratrol (RSV), a natural polyphenol, has been reported to attenuate nonalcoholic fatty liver disease (NAFLD); however, its underlying mechanism is... 
NAFLD | Treatment | Hepatocyte | SIRT1 | Resveratrol | ACTIVATION | LIPID-METABOLISM | PROTEIN-KINASE | FOOD SCIENCE & TECHNOLOGY | NONALCOHOLIC FATTY LIVER | DIET | INFLAMMATION | DISEASE | AMPK | HEALTH | Sirtuin 1 - metabolism | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Stilbenes - therapeutic use | Antioxidants - metabolism | Humans | Stilbenes - metabolism | Mice, 129 Strain | Sirtuin 1 - genetics | Autophagy - drug effects | Fatty Acids, Nonesterified - metabolism | Liver - drug effects | RNA Interference | Enzyme Induction - drug effects | Sirtuin 1 - chemistry | Cyclic AMP - metabolism | Fatty Acids, Nonesterified - adverse effects | Microscopy, Electron, Transmission | Second Messenger Systems - drug effects | Liver - ultrastructure | Liver - metabolism | Enzyme Inhibitors - pharmacology | Non-alcoholic Fatty Liver Disease - metabolism | Adenylyl Cyclases - metabolism | Sirtuin 1 - antagonists & inhibitors | Hep G2 Cells | Cyclic AMP - antagonists & inhibitors | Antioxidants - therapeutic use | Animals | Adenylyl Cyclases - chemistry | Lipid Metabolism - drug effects | Fatty Acids, Nonesterified - antagonists & inhibitors | Cyclic AMP - agonists | Non-alcoholic Fatty Liver Disease - diet therapy | Adenylyl Cyclases - genetics | Dietary Supplements | Triglycerides | Liver diseases | Fatty acids | Liver | Index Medicus
Journal Article
Vascular Health and Risk Management, ISSN 1176-6344, 2013, Volume 9, Issue 1, pp. 563 - 573
The systemic bioavailability of free fatty acid (FFA) forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) compared with ethyl ester (EE) forms... 
Docosahexaenoic acid | Pharmacokinetics | Hypertriglyceridemia | Eicosapentaenoic acid | Esters - adverse effects | Area Under Curve | Cholesterol - blood | Humans | Eicosapentaenoic Acid - adverse effects | Fatty Acids, Omega-3 - chemistry | Biological Availability | Fatty Acids, Nonesterified - administration & dosage | Male | Eicosapentaenoic Acid - administration & dosage | Esters - chemistry | Fatty Acids, Nonesterified - blood | Female | Fatty Acids, Nonesterified - adverse effects | Fatty Acids, Omega-3 - administration & dosage | Eicosapentaenoic Acid - chemistry | Administration, Oral | Docosahexaenoic Acids - chemistry | Docosahexaenoic Acids - administration & dosage | Docosahexaenoic Acids - pharmacokinetics | Chemistry, Pharmaceutical | Fatty Acids, Nonesterified - pharmacokinetics | Eicosapentaenoic Acid - blood | Fatty Acids, Omega-3 - pharmacokinetics | Docosahexaenoic Acids - blood | Models, Biological | Diet, Fat-Restricted | Eicosapentaenoic Acid - pharmacokinetics | Esters - administration & dosage | Triglycerides - blood | Esters - blood | Fatty Acids, Nonesterified - chemistry | Least-Squares Analysis | Fatty Acids, Omega-3 - blood | Esters - pharmacokinetics | Dietary Supplements | Docosahexaenoic Acids - adverse effects | Fatty Acids, Omega-3 - adverse effects | Drug Combinations | Care and treatment | Usage | Hyperlipidemia | Statistics | Fatty acids | Health aspects | Low-fat diet | Cardiovascular disease | Bioavailability | Diet | Index Medicus | hypertriglyceridemia | pharmacokinetics | eicosapentaenoic acid | Original Research | docosahexaenoic acid
Journal Article
Journal of the Science of Food and Agriculture, ISSN 0022-5142, 03/2014, Volume 94, Issue 5, pp. 929 - 934
BACKGROUND Apple pomace is generated in huge quantities in juice-processing industries the world over and continuous efforts are being made for its inclusive... 
linoleic acid | palmitic acid | cytotoxicity | physiochemical properties | apple seed oil | oleic acid | Cytotoxicity | Physiochemical properties | Apple seed oil | Palmitic acid | Oleic acid | Linoleic acid | FOOD SCIENCE & TECHNOLOGY | AGRICULTURE, MULTIDISCIPLINARY | COMPONENTS | CHEMISTRY, APPLIED | EXTRACTS | Fatty Acids - adverse effects | Cricetulus | Humans | Oleic Acid - adverse effects | Linoleic Acid - economics | Linoleic Acid - adverse effects | Linoleic Acid - analysis | Antioxidants - economics | Fatty Acids, Nonesterified - economics | Chemical Phenomena | Food Preservatives - economics | Seeds - chemistry | Dietary Supplements - adverse effects | Oleic Acid - analysis | Oleic Acid - economics | Antineoplastic Agents, Phytogenic - adverse effects | CHO Cells | Fatty Acids, Nonesterified - adverse effects | Plant Oils - economics | Plant Oils - pharmacology | Fruit - chemistry | Malus - chemistry | Fatty Acids - analysis | Food Preservatives - pharmacology | Antioxidants - pharmacology | Plant Oils - isolation & purification | Fatty Acids, Nonesterified - analysis | Industrial Waste - analysis | India | Industrial Waste - economics | Dietary Supplements - economics | Fatty Acids - economics | Animals | Antineoplastic Agents, Phytogenic - economics | Antioxidants - isolation & purification | Food Preservatives - isolation & purification | Fruit - economics | Cell Line, Tumor | Antioxidants - adverse effects | Cell Proliferation - drug effects | Antineoplastic Agents, Phytogenic - pharmacology | Food Preservatives - adverse effects | Plant Oils - chemistry | Food-Processing Industry - economics | Antineoplastic Agents, Phytogenic - isolation & purification | Antioxidants | Monounsaturated fatty acids | Seeds | Saturated fatty acids | Apples | Nutrition research | Physical chemistry | Oils & fats | Fatty acids | Index Medicus | Biotechnology | In vitro testing | Foods | Apple pomace
Journal Article
The Journal of Nutritional Biochemistry, ISSN 0955-2863, 07/2015, Volume 26, Issue 7, pp. 769 - 775
Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), known as ω-3 polyunsaturated fatty acid (PUFA), are common nutrients in daily food intake and have... 
Polyunsaturated fatty acid | Lipidomics | Mitochondria | Cardiolipin | DHA and EPA | Mass spectrometry | OMEGA-3-FATTY-ACIDS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CYTOCHROME-C | HEART | NUTRITION & DIETETICS | METABOLISM | DOCOSAHEXAENOIC ACID | BIOSYNTHESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | FISH | Mitochondria, Heart - metabolism | Molecular Weight | Eicosapentaenoic Acid - adverse effects | Fatty Acids, Omega-3 - chemistry | Chromatography, High Pressure Liquid | Fatty Acids, Nonesterified - metabolism | Tandem Mass Spectrometry | Dietary Fats, Unsaturated - metabolism | Myoblasts - metabolism | Osmolar Concentration | Molecular Structure | Fatty Acids, Nonesterified - adverse effects | Cell Line | Eicosapentaenoic Acid - chemistry | Fatty Acids, Omega-3 - metabolism | Cell Survival | Docosahexaenoic Acids - chemistry | Eicosapentaenoic Acid - metabolism | Models, Molecular | Rats | Cardiolipins - metabolism | Dietary Fats, Unsaturated - adverse effects | Fatty Acids, Omega-6 - metabolism | Cardiolipins - chemistry | Animals | Fatty Acids, Omega-6 - chemistry | Fatty Acids, Nonesterified - chemistry | Dietary Supplements | Docosahexaenoic Acids - adverse effects | Fatty Acids, Omega-3 - adverse effects | Docosahexaenoic Acids - metabolism | Fatty Acids, Omega-6 - adverse effects | Membrane lipids | Unsaturated fatty acids | Analysis | Mitochondrial DNA | Chemical properties | Biological monitoring | Omega-3 fatty acids | Index Medicus
Journal Article
Diabetologia, ISSN 0012-186X, 3/2012, Volume 55, Issue 3, pp. 773 - 782
Journal Article
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 2014, Volume 79, pp. 1 - 12
Journal Article
Metabolism, ISSN 0026-0495, 2014, Volume 63, Issue 9, pp. 1131 - 1140
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 04/2014, Volume 276, Issue 1, pp. 73 - 81
Although non-alcoholic fatty liver disease (NAFLD) is currently the most common form of chronic liver disease there is no pharmacological agent approved for... 
Fatty acid oxidation | Hepatocytes | Non-alcoholic steatohepatitis | Hepatotoxicity | Fatty acid overload | BETA-OXIDATION | GAMMA | CYTOCHROMES P450 | FATTY LIVER-DISEASE | NUCLEAR RECEPTORS | NONALCOHOLIC STEATOHEPATITIS | RECEPTOR-ALPHA/GAMMA AGONIST | BODY-FAT | IN-VITRO | PHARMACOLOGY & PHARMACY | TOXICOLOGY | HEPATIC STEATOSIS | Glycine - analogs & derivatives | Humans | Oleic Acid - adverse effects | Orphan Nuclear Receptors - metabolism | PPAR gamma - metabolism | Liver - drug effects | Liver X Receptors | Non-alcoholic Fatty Liver Disease | Drug Evaluation, Preclinical | Fatty Acids, Nonesterified - adverse effects | Peroxisome Proliferator-Activated Receptors - agonists | Cell Line | Fatty Liver - metabolism | Oxidation-Reduction | Liver - metabolism | Receptors, Cytoplasmic and Nuclear - genetics | Orphan Nuclear Receptors - genetics | Fatty Liver - drug therapy | Triglycerides - metabolism | Gene Expression Regulation - drug effects | Orphan Nuclear Receptors - antagonists & inhibitors | Glycine - pharmacology | Lipogenesis - drug effects | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Lipid Metabolism - drug effects | PPAR gamma - agonists | Peroxisome Proliferator-Activated Receptors - metabolism | Lipotropic Agents - pharmacology | PPAR alpha - agonists | Oxazoles - pharmacology | PPAR alpha - metabolism | Receptors, Cytoplasmic and Nuclear - metabolism | Monounsaturated fatty acids | Triglycerides | Index Medicus | Oleic Acid | Liver | Gene Expression Regulation | PPAR alpha | Lipid Metabolism | Pharmacology | Glycine | PPAR gamma | Receptors, Cytoplasmic and Nuclear | Fatty Liver | Life Sciences | Oxazoles | Peroxisome Proliferator-Activated Receptors | Fatty Acids, Nonesterified | Lipotropic Agents | Orphan Nuclear Receptors | Lipogenesis | Pharmaceutical sciences | OXIDATION | TRIGLYCERIDES | IN VIVO | PATHOLOGY | 60 APPLIED LIFE SCIENCES | OLEIC ACID | DISEASES | METABOLISM | IN VITRO | GENES | LIVER | LIVER CELLS | RECEPTORS
Journal Article